INDIANAPOLIS — Marjorie Rallins, DPM, MS, has been elected to the Health Level Seven® (HL7®) International Board of Directors during the 37th Annual Plenary Meeting, Working Group Meeting, and HL7® FHIR® Connectathon in Phoenix, Arizona.
As a Director on the HL7® Board of Directors, Dr. Rallins will provide insight into the continued development and maintenance of the HL7® strategic plan. She will also help create advisory groups and councils to fulfill liaison duties with partner organizations and confirm recommended appointments for representatives of those partners. Dr. Rallins will serve on the Board from January 1, 2024 to December 31, 2025.
A nationally recognized leader in clinical standards and informatics, Dr. Rallins began his duties with the Regenstrief Institute in January 2021. She guides the Health Data Standards Unit in managing LOINC® and UCUM (Unified Code for Units of Measurement) and serving as focal. Point for data standards initiatives and policies in the Regenstrief. She previously served as vice president and chief scientific officer of the PCPI® Foundation in Chicago, as well as director of clinical informatics and business strategies for the American Medical Association. His proven unparalleled experience in clinical data standards, business development and thought leadership positions Regenstrief to continue facilitating healthcare interoperability across a broad spectrum of partners.
Regenstrief and HL7® have had an agreement since 2011 to create a complementary process to develop and expand comprehensive standards across the healthcare industry. HL7® is a key stakeholder and collaborator with Regenstrief and the data standards community.
At HL7® Working Group meetings, attendees have the opportunity to meet face-to-face to work on the standards, as well as network with industry leaders from around the world. The international meeting also provides attendees with an educational resource for the healthcare IT community.
About the Regenstrief Institute
Founded in Indianapolis in 1969, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information enables people to eliminate disease and realize true health. A major research partner of Indiana University, Regenstrief and its research scientists are responsible for a growing number of major health care innovations and studies. Examples include the development of global health information technology standards that enable the use and interoperability of electronic health records to improve patient-physician communication, creating models of care that inform clinical practice. and improve the lives of patients around the world.
Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making health care more efficient and accessible for all. His vision continues to guide the research mission of the institute.
About Health Level Seven® International (HL7®)
HL7 is an ANSI-accredited, non-profit standards developing organization with a mission to empower global health interoperability. With affiliates in more than 30 countries, HL7’s global membership envisions a world in which everyone can securely access the right data and use it when and where they need it. Widely implemented by vendors and healthcare systems, and required by governing bodies around the world, the HL7 standards provide solutions for health information technology, including HL7® Fast Healthcare Interoperability Resources (FHIR®), version 2 (V2) and Clinical Document Architecture (CDA®). ,
Disclaimer: AAAS and EurekAlert! EurekAlert is not responsible for the accuracy of news releases posted! For the use of any information by contributing to institutions or through the EurekAlert system.